Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
JASINT1: Vinflunine combinations in advanced urothelial carcinoma
NCT01599013Phase 2Completed
- Sponsor
- Pierre Fabre Laboratories
- Start
- Feb 2011
- Primary completion
- Oct 2013
- Modality
- Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of vinflunine in urothelial carcinoma (UC), sponsored by Pierre Fabre Laboratories. Started Feb 2011; status: completed.
02
Drugs
vinflunine
03
Conditions
urothelial carcinoma (UC)
Beyond the preview
Go deeper on NCT01599013.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01599013.